Colorectal cancer (CRC) is the third most common malignancy worldwide, with
approximately 50% of patients developing colorectal cancer liver metastasis (CRLM) during …

Simple Summary This paper reviewed an update on the molecular detection of gastric
cancers, focusing on various diagnostic approaches, including nonblood analytes …

Background Screening endoscopy is considered to be the most accurate tool for early
detection of gastric cancer, but it is both invasive and costly. It is therefore essential to …

Simple Summary Gastrointestinal (GI) cancers are a common cancer, affecting both men
and women, normally diagnosed through tissue biopsies in combination with imaging …

Pancreatic adenocarcinoma (PDAC) is one of the most common and lethal human cancers
worldwide. Surgery followed by adjuvant chemotherapy offers the best chance of a long …

Developing on‐site biomarker enrichment platforms could help to improve the diagnosis of
gastrointestinal (GI) tract diseases at early stages. Medical procedures, such as …

This study was designed to monitor circulating tumor DNA (ctDNA) levels during
perioperative chemotherapy in patients with non-metastatic gastric adenocarcinoma …

Immunotherapy has revolutionized the conventional treatment approaches for colorectal
cancer (CRC), offering new therapeutic prospects for patients. Liquid biopsy has shown …

The emerging era of precision medicine is characterized by an increasing availability of
targeted anticancer therapies and by the parallel development of techniques to obtain more …

The use of blood liquid biopsy is increasingly being incorporated into the clinical setting of
gastrointestinal cancers care. Clonal hematopoiesis (CH) occurs naturally as a result of the …